Download Unicorn Signals App

Powered By EquityPandit
Latest News

Dr Reddy gets EIR for Cuernavaca plant in Mexico from USFDA

Dr Reddy’s Laboratories has received establishment inspection report for its Cuernavaca facility in Mexico, from the US health regulator.

In a filing to BSE the company stated, “..we have received an Establishment Inspection Report (EIR) from the USFDA, for the above-referred facility.” Dr Reddy in an earlier regulatory filing stated that, audit of its active pharmaceutical ingredient (API) Cuernavaca plant in Mexico, by the United States Food and Drug Administration (USFDA) was completed with zero observations.

Moreover, as per the USFDA regulations an EIR is issued to a company dealing inspection findings, only after the completion of an inspection of a facility.

Read EquityPandit’s Technical Analysis of Dr Reddy 

Get Daily Prediction & Stocks Tips On Your Mobile